Skip to main content
Category

News Archive

University of Maryland Logo

Research Hailed for Making the World a Better Place – University of Maryland, Baltimore

By News Archive

University of Maryland Logo

The University of Maryland School of Medicine is being recognized by a national news publication for groundbreaking biomedical research that “is making the world a better place.” The publication, WIRED magazine, is featuring the innovative work of UMSOM’s Samuel Tisherman, MD, professor of surgery, and the University of Maryland R Adams Cowley Shock Trauma Center on a list of 19 items or advances recognized in 2019. 

 

Read More
intrexon logo

Intrexon To Achieve $175M Cash Goal, Appoints Helen Sabzevari, PhD, As New President And CEO And Will Change Name To Precigen To Reflect Healthcare Focus

By News Archive

intrexon logo

GERMANTOWN, Md., Jan. 2, 2020 /PRNewswire/ — Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, announced today that it will refocus the company on healthcare, change its name to Precigen, Inc. and, effective immediately, has appointed Helen Sabzevari, PhD, as President and CEO. The new Precigen will encompass Intrexon’s wholly-owned healthcare subsidiaries Precigen, ActoBio Therapeutics, Exemplar Genetics, and its majority ownership interest in Triple-Gene, as well as equity and royalty interests in therapeutics and therapeutic platforms from companies not controlled by Intrexon. Randal J. Kirk has been appointed Executive Chairman.  Additionally, Intrexon has executed binding agreements to sell its smaller non-healthcare businesses for $65.2M plus certain contingent payment rights and entered into an agreement to sell $35M of its common stock.  The proceeds from these transactions, combined with the company’s cash and short-term investments on hand at December 31, 2019, approximates $175 million thus attaining Intrexon’s year-end objective.

 

Read More
NewImage

The Top 25 Women Leaders In Biotech of 2019 | The Healthcare Technology Report.

By News Archive

NewImage

The Healthcare Technology Report is pleased to announce and recognize a unique set of accomplished women playing vital roles in some of the most important global companies shaping the future of biotechnology. The awardees of 2019 were each selected based on a detailed review of the depth of their professional experience and the caliber of their career achievements. These women are leaders not only in title or position but based on what they’ve been able to accomplish inspiring the teams and organizations around them. They have also demonstrated a commitment to the advancement of biotech. We congratulate each of this year’s awardees of The Top 25 Woman Leaders In Biotech of 2019.

Image: https://thehealthcaretechnologyreport.com

Read More
Tedco Logo

Applications Now Open for TEDCO’s Investment Funds | TEDCO

By News Archive

CTedco LogoOLUMBIA, Md. (January 3, 2020)—TEDCO, Maryland’s economic engine for technology companies, announced today that its programs: Rural Business Innovation Initiative (RBII Fund), Builder Fund (Builder Fund), Seed Funds (Seed Fund) and Maryland Venture Fund (MVF) are now accepting applications for investments. 

In accordance with new statutory requirements enacted by the Maryland General Assembly during the 2019 legislative session, TEDCO has developed and adopted regulations governing its investment programs.  The new law also tasked TEDCO with developing an application process for its investment programs. With the new regulations in place and a compliant on-line application portal up and running, TEDCO is now able to begin accepting applications.  

 

Read More
NewImage

2019’s Top 10 Most Read Biotech News Stories from the BioHealth Capital Region · BioBuzz

By News Archive

NewImage

2019 was an eventful year in the BioHealth Capital Region (BHCR), to say the least, and BioBuzz has been there to document it every step of the way.

Whether it was the retirement of the MedImmune brand, Viela Bio’s $150M IPO, the $1.2B acquisition of Paragon Bioservices, Kite Pharma’s new manufacturing site in Frederick County, Maryland, an HIV cure emerging in Maryland or our continued coverage of the region’s expanding cell and gene therapy cluster-it’s been a truly remarkable year within the BHCR.

Image: https://biobuzz.io

Read More
Home Precigen

Precigen Receives FDA Orphan Drug Designation for PRGN-3006 UltraCAR-T(TM) in Patients with Acute Myeloid Leukemia (AML) | P&T Community

By News Archive

Home Precigen

GERMANTOWN, Md., Jan. 6, 2020 /PRNewswire/ — Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to PRGN-3006, a first-in-class investigational therapy using Precigen’s non-viral UltraCAR-T™ therapeutic platform for patients with relapsed or refractory acute myeloid leukemia (AML) (clinical trial identifier: NCT03927261). Precigen announced in Q3 2019 that it had completed enrollment for the first cohort of this clinical trial and expects an initial data readout in the second half of 2020.

 

Read More
low carb

NEW HEALTH COALITION PUSHES FOR LOW-CARB DIET INCLUSION IN US NUTRITION GUIDELINES | Black Star News

By News Archive

low carb

Low-carb diet success story Sabrina Williams, above, who drastically reduced her weight from 257 pounds.

A new group called the Low-Carb Action Network (LCAN), a coalition of doctors, academics, and average Americans with personal success stories using low-carb diets, has launched to urge U.S. nutrition leaders to include a true low-carb diet as part of the 2020 Dietary Guidelines for Americans (DGA).

LCAN members point to a large and rapidly growing body of strong scientific research showing carbohydrate restriction to be a safe and effective strategy to prevent and even reverse chronic, diet-related conditions such as pre-diabetes/type 2 diabetes, overweight/obesity, and high blood pressure along with a broad array of other cardiovascular risk factors.

 

Read More
MaxCyte Logo

MaxCyte Appoints New Executive Vice President, Business Development for CARMA™ Cellular Therapies and Provides Clinical Trial Update

By News Archive

MaxCyte Logo

GAITHERSBURG, Md., Dec. 19, 2019 /PRNewswire/ — MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that Shruti Abbato has joined the Company as Executive Vice President, Business Development for CARMA Cellular Therapies. Ms. Abbato will lead development of new partnerships for the Company’s CARMA platform programmes. 

 

Read More
NewImage

Johns Hopkins To Close Rockville Biotech Center

By News Archive

NewImage

Johns Hopkins University will close its graduate programs in Rockville by the summer of 2020, dealing a blow to the county’s ambitions of expanding higher education opportunities.

The university plans to consolidate the Center for Biotechnology Education on Medical Center Drive with the program’s main campus in Baltimore, said Leslie Ford Weber, the director of campus, government and community affairs for Johns Hopkins in Montgomery County.

Image: https://bethesdamagazine.com

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.